ZA891594B - 1,2-hydroxy phosphonates and derivatives thereof - Google Patents

1,2-hydroxy phosphonates and derivatives thereof

Info

Publication number
ZA891594B
ZA891594B ZA891594A ZA891594A ZA891594B ZA 891594 B ZA891594 B ZA 891594B ZA 891594 A ZA891594 A ZA 891594A ZA 891594 A ZA891594 A ZA 891594A ZA 891594 B ZA891594 B ZA 891594B
Authority
ZA
South Africa
Prior art keywords
derivatives
hydroxy phosphonates
phosphonates
hydroxy
Prior art date
Application number
ZA891594A
Other languages
English (en)
Inventor
Dinesh V Patel
V Patel Dinesh
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of ZA891594B publication Critical patent/ZA891594B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/32—Esters thereof
    • C07F9/3205—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/3211—Esters of acyclic saturated acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/44—Amides thereof
    • C07F9/4403—Amides thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4407—Amides of acyclic saturated acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503—Five-membered rings
    • C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
    • C07F9/6539—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA891594A 1988-03-03 1989-03-01 1,2-hydroxy phosphonates and derivatives thereof ZA891594B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16359388A 1988-03-03 1988-03-03

Publications (1)

Publication Number Publication Date
ZA891594B true ZA891594B (en) 1989-11-29

Family

ID=22590702

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA891594A ZA891594B (en) 1988-03-03 1989-03-01 1,2-hydroxy phosphonates and derivatives thereof

Country Status (6)

Country Link
EP (1) EP0331105A3 (fr)
JP (1) JPH02503440A (fr)
AU (1) AU3099989A (fr)
HU (1) HUT52785A (fr)
WO (1) WO1989007940A1 (fr)
ZA (1) ZA891594B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990009172A1 (fr) * 1989-02-16 1990-08-23 Pfizer Inc. Inhibiteurs de renine contenant du phosphore
US5468732A (en) * 1989-02-16 1995-11-21 Pfizer Inc. Phosphorus containing renin inhibitors
US5098924A (en) * 1989-09-15 1992-03-24 E. R. Squibb & Sons, Inc. Diol sulfonamide and sulfinyl renin inhibitors
WO1992001468A1 (fr) * 1990-07-25 1992-02-06 The Green Cross Corporation Inhibiteur d'enzyme de conversion d'endoserine ou remede contre les contractions vasculaires

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL48835A (en) * 1975-01-27 1979-05-31 Sparamedica Ag Amino acyl and peptidyl derivatives of phophonic acids, their preparation and pharmaceutical compositions containingthem
GB1585076A (en) * 1976-07-13 1981-02-25 Roche Products Ltd Peptides of phosphonic and phosphinic acids
GB1585275A (en) * 1976-07-21 1981-02-25 Roche Products Ltd Peptide derivatives of phosphonic and phosphinic acids
CA1108125A (fr) * 1977-12-23 1981-09-01 Frank R. Atherton Derives oligopeptides de l'acide phosphonique
US4416831A (en) * 1981-04-27 1983-11-22 E. R. Squibb & Sons, Inc. Amino and substituted amino phosphinylalkanoyl compounds
US4416833A (en) * 1981-05-04 1983-11-22 E. R. Squibb & Sons, Inc. Substituted carbonyl phosphinyl-alkanoyl compounds
US4432971A (en) * 1981-08-03 1984-02-21 E. R. Squibb & Sons, Inc. Phosphonamidate compounds
US4716155A (en) * 1981-12-24 1987-12-29 E. R. Squibb & Sons, Inc. Phosphorus containing compounds and hypotensive use thereof
US4555506A (en) * 1981-12-24 1985-11-26 E. R. Squibb & Sons, Inc. Phosphorus containing compounds and use as hypotensives
US4560680A (en) * 1982-03-15 1985-12-24 E. R. Squibb & Sons, Inc. Aminoalkyl and related substituted phosphinic acid angiotensin converting enzyme inhibitors
EP0103867B1 (fr) * 1982-09-17 1986-12-17 Kyowa Hakko Kogyo Co., Ltd. Dérivé de peptide contenant du phosphore
CA1307787C (fr) * 1986-06-11 1992-09-22 Melanie J. Loots Inhibiteurs de l'enzyme de conversion de l'angiotensine, a base d'aminoalcanoylamino-alkylphosphonate a substitution
MY103189A (en) * 1986-10-31 1993-05-29 Pfizer Nor-statine and nor-cyclostatine polypeptides
DE3825242A1 (de) * 1987-07-27 1989-02-09 Ciba Geigy Ag Durch schwefelhaltige gruppen substituierte histidinylamino-verbindungen

Also Published As

Publication number Publication date
WO1989007940A1 (fr) 1989-09-08
JPH02503440A (ja) 1990-10-18
EP0331105A2 (fr) 1989-09-06
HUT52785A (en) 1990-08-28
HU8902302D0 (en) 1990-05-28
AU3099989A (en) 1989-09-07
EP0331105A3 (fr) 1990-09-05

Similar Documents

Publication Publication Date Title
GB8905443D0 (en) Dihalogrnobenzene derivatives
GB2222828B (en) Butynylamine derivatives
PH27571A (en) Capsiacin derivatives
EG19385A (en) N-phenylpyrazol -4-yl-ether derivatives
GB8901863D0 (en) Acylphenol derivatives
ZA89860B (en) Pyranobenzoxadiazole derivatives
AU103615S (en) 20 july 1988
PH27235A (en) Benzopyranol derivatives
ZA892723B (en) Phosphonoalkylpurine derivatives
GB2222829B (en) Benzylidenecyclanone derivatives
YU200589A (en) Derivatives 3-acyl-2-oxyndol-1-carboxamida
ZA891594B (en) 1,2-hydroxy phosphonates and derivatives thereof
EP0355353A3 (en) Cycloalkylthiazole derivatives
ZA898604B (en) Pyranylethyl-naphthalene derivatives
ZA90301B (en) 8,9-annelated-1,2,3,4-tetrahydro-beta-carboline derivatives
ZA893169B (en) 3-cyano-4-phenyl-pyrrole derivatives
ZA895454B (en) 2,2-dihalogenocy-clopropyl-hydroxy-ethyltriazoles
ZA899582B (en) Benzohydroxymic derivatives
ZA891059B (en) 1-aminomethyl-3-(2,4-difluoro-3-chlorophenyl)-4-cyano-pyrroles
IL92606A0 (en) Sphingenine and derivatives thereof
ZA899367B (en) 4,5,6,7-tetrahydrobenzimidazole derivatives
IE881998L (en) 1 h-pyrazole-1-alkanamides
IE881104L (en) 2,3-bicyclopyrazolidinones
IE883873L (en) 1-aralkyl-1,2,-dihydropyrimidine-2-thiones
CS267188A1 (en) 1,2,2,6,6-pentamethyl-4-allyloxypiperidine